Brain Trauma Foundation

International Healthcare Week returns to showcase Hong Kong's strengths in healthcare innovation and investment

Retrieved on: 
Thursday, May 4, 2023

"The second IHW provides the perfect opportunity to bring together the world's elite in the medical, research and financial fields in Hong Kong," she added.

Key Points: 
  • "The second IHW provides the perfect opportunity to bring together the world's elite in the medical, research and financial fields in Hong Kong," she added.
  • "Our partnerships make this event very meaningful and highlights the importance of collaboration to drive forward the healthcare industry.
  • They will discuss the latest developments in public health, medical technology and healthcare investment and explore the future of the healthcare ecosystem and opportunities within it.
  • Also on day one, the InnoHealth Showcase and exhibition area at the HKCEC will feature more than 140 healthcare start-ups.

BrainTree Nutrition Launched Products to Provide Second Line of Protection for NFL Players

Retrieved on: 
Monday, December 5, 2022

Austin, Texas--(Newsfile Corp. - December 4, 2022) - BrainTree Nutrition launched a supplement line to help reduce the risk of brain diseases among people, especially athletes.

Key Points: 
  • Austin, Texas--(Newsfile Corp. - December 4, 2022) - BrainTree Nutrition launched a supplement line to help reduce the risk of brain diseases among people, especially athletes.
  • This new product line will serve as the second protection for the brain after the helmet.
  • The Braintree Nutrition™ supplement line includes four products that work synergistically together to optimize the brain’s ability to function at the highest output:
    BrainTree Nutrition does not use proprietary blends.
  • More than 20 active NFL players are already using the products of BrainTree Nutrition.

Neurovation Labs Announces Issuance of Second U.S. Patent Covering Compositions and Methods for Detecting PTSD Biomarker

Retrieved on: 
Wednesday, September 14, 2022

The patent, entitled "Compositions and Methods to Detect GluA1 in Brain and to Identify the Presence of GluA1-Mediated Post-Traumatic Stress Disorder and Other Neurological Disorders," is directed to novel radiotracer compositions as well as methods for detecting GluA1 and GluA1-containing central nervous system receptors.

Key Points: 
  • The patent, entitled "Compositions and Methods to Detect GluA1 in Brain and to Identify the Presence of GluA1-Mediated Post-Traumatic Stress Disorder and Other Neurological Disorders," is directed to novel radiotracer compositions as well as methods for detecting GluA1 and GluA1-containing central nervous system receptors.
  • "The compounds protected by this patent are part of a series of radiotracers that Neurovation Labs is developing to enable objective diagnosis of brain disorders and to better evaluate the mechanisms underlying PTSD and other brain traumas.
  • This patent is owned solely by Neurovation Labs and is the second issuance from a broader intellectual property portfolio stemming from the company's research and development.
  • Neurovation Labs is a biotechnology company revolutionizing the way psychiatric disorders are diagnosed and treated, with an initial focus on PTSD.

Neurovation Labs Awarded Additional Air Force Phase II Contract Worth $1.25M to Develop Tools to Mitigate PTSD and Other Brain Traumas

Retrieved on: 
Tuesday, June 21, 2022

Two of the most significant issues affecting long-term soldier health are TBI and PTSD, which often occur together.

Key Points: 
  • Two of the most significant issues affecting long-term soldier health are TBI and PTSD, which often occur together.
  • Neurovation Labs is addressing critical shortcomings in brain trauma healthcare by assessing and targeting underlying biomarkers.
  • Neurovation Labs is targeting a localized protein increase in the brain to develop the first diagnostic brain scan and companion medication for the disorder.
  • Neurovation Labs is a biotechnology company revolutionizing the way mental health disorders are diagnosed and treated, focusing on PTSD and other brain traumas.

Cohen Veterans Bioscience, Stanford Brain Performance Center, and Brain Trauma Foundation Join Forces to Advance Precision Medicine for TBI

Retrieved on: 
Monday, August 9, 2021

"The Stanford Brain Performance Center and the Brain Trauma Foundation have advanced our understanding of best practices for traumatic brain injury.

Key Points: 
  • "The Stanford Brain Performance Center and the Brain Trauma Foundation have advanced our understanding of best practices for traumatic brain injury.
  • The Stanford Brain Performance Center is an interdisciplinary center in the Stanford school of medicine.
  • Founded in 1986 by Dr. Ghajar, the Brain Trauma Foundation was created to improve outcome from TBI.
  • The Brain Trauma Blueprint is a framework to advance precision diagnostics and therapeutics for brain trauma through a process of community stakeholder consensus roadmapping and collaborative execution.

Utilize Health Releases Ground-Breaking White Paper On The Cost and Human Toll of Neuro Conditions

Retrieved on: 
Tuesday, August 13, 2019

NASHVILLE, Tenn., Aug. 13, 2019 /PRNewswire/ --Targeted neurological care solutions company Utilize Health has released an innovative white paper on The Cost and Human Toll of Neurological Conditions.

Key Points: 
  • NASHVILLE, Tenn., Aug. 13, 2019 /PRNewswire/ --Targeted neurological care solutions company Utilize Health has released an innovative white paper on The Cost and Human Toll of Neurological Conditions.
  • The publication focuses on the challenges of individuals, health plans, and health systems in managing traumatic brain injury (TBI).
  • Utilize Health's paper draws from a growing body of literature on the rising prevalence of TBI in America and its dramatic impact on healthcare quality and medical cost.
  • A recent neuro-specific claims analysis conducted by Utilize Health for a mid-sized health plan identified more than $40 million in quality driven medical cost savings opportunities.

New Jersey Researchers Link Admission Scores With Recovery Patterns in Pediatric Brain Injury

Retrieved on: 
Tuesday, January 8, 2019

The article, "The evidence of admission functional independence on early recovery in pediatric traumatic and nontraumatic brain injury" was published in a special issue of the Journal of Head Trauma Rehabilitation (2018 Nov/Dec;33(6):E11-E18.

Key Points: 
  • The article, "The evidence of admission functional independence on early recovery in pediatric traumatic and nontraumatic brain injury" was published in a special issue of the Journal of Head Trauma Rehabilitation (2018 Nov/Dec;33(6):E11-E18.
  • The study is the first to examine the child's level of function at admission as a predictor of gains during inpatient rehabilitation for brain injury.
  • The findings underscore the differences in TBI recovery patterns between adult and pediatric populations.
  • This retrospective study, which focused on outcomes of pediatric inpatient rehabilitation for acquired brain injury, including traumatic (TBI) and nontraumatic (nTBI), revealed the level of function at time of admission to be an important predictor of recovery.